Free Statement - District Court of Arizona - Arizona

EXHIBIT 10 I
Case 2:03-cv-01729-RCB Document 83-13 Filed 10/31/2005 Page1 014

NATIONA [EALTH LABORATORIES INCORPORATE. Phoenix 4 I
I 4 - 1225 -s_ zaam STREET-99 9 I v I v 4; PAGE: 1
6/14/99 I 9 PHDENIX, Az-85034 9(6/02-244»9431)9 9 , ~ 4 I-4;f;9;4e%-38PMI
4 84-0`611484 - 9 ; f 44 -9 9 - 94` 49/9;,-03/8007/ 5 444/9 4 ,4 I9~4-·; 44
~24PA'I‘IENT* NAME P; MAR`TINEZ,FELIPE I ¤ 4 4 - 0/ iA@cESSI0NI 1; :;:43813159I89_5;49i;; 49//i9 4’-,Ii - ///4}9 {9
4- ;PAT-IIENT ID .; 1042001 -4/4 ‘ i 94 /4_;_ ;y4¤-S;904iI/REQU4I4SiITII4QN 9‘1 ig
J ·999 PATIENT`- PHONE: I I ` 4 ; RTA. 5 I44A * »4»/ PQEPORTED-4 J: TII4
‘ QHOSPITAL- ID- E 9 ” 1 ‘ I -I4”` { /--1R ‘ / I IIIT 3 - YF-?} -TT1 1T,R i -I 1—9 I -1‘, I 19-44_ ;i*”=:`RE-CE;I;VE4Di /1—I t I--;4
*’SEX= M - AGE=*3‘6 -iDOBAQQJ25+FEB-l96[3?9Y-YY°‘?*9‘ » j - 4 Y R1— 9-.‘
‘ss‘#· 000A00-- 090009 WARD --4-- I 9- `-ROOM ;-/Ji -4-- f5 -,4I-9 i --4II - —·11 9;-isi 9, _--- z T4-44
PHYSICIANARR 4 D SCHEETZ; D0 9 I I YPHYS/UPIN#ez?9.;;;-9e}994;;, , P4I» 1; 41;- 9 /-I` 4»I.
9;-CLIENT NAME ASPC I- —- DAKDTAI/4-994;*-L PII- I4I/P -9-39cL-IENTgID,.:1,148-`IO6§5{>~L ; I iiig ·_‘ 5 4`44.
44TEST REQUEST :9 AUT409fcHEMIsTR4IEs,FERRITIN;4THYR09I4D;;1cBc4;4THYR0IDj -4_’
9 4 4 I- Hép B S4¤ff&¤é`-AQ. IRON- 0 - mac)-PRGTHRGMBIM-I-TIME;/SE 09 9 --0I
9- I A I 9-;P gi.IRHBUMAT/PID-9-Imwmlwrs FACTOR} ·P‘S PTT}
9»1‘ 9 5 4.- r-fe; 44 9 I.4-44 33 I I -B/9IL=1RuB941N?,1 DIRECT 41EiiT0T1-m* II 91I` 4 9I- f-; “P·91 i YQ -
I-AD¤fTI<>NAL— 40-R0·, I 9’0— -19I 9 R."/9 RPA9 /’-1-
FASTINGT IE-°HE“IS3HT1=`EAWETYGHT -‘RR I { I9991 L 994`9 9 iY*4 2i -99I S4-‘ ``R`”
AVOLUME-A A · sumzcz 9 (cm/NICAL1 ¤II ;;gP.4L00DI/Q AN'rIB-191:1/¢;s IPIP :9 ·IR/
99PRF·VI¤¤S SMEPQR ‘DA1‘ET=9~iIi9 31-11i;DEC-=51 899-9/ PRI90R9;€fJ9§¤1駧#?: -`*‘- 9 {9-T-‘ * ,
P.I4 9PRE0PERA’HVE RI94R 1313*-GN¤SI$é??‘i /-*, I»MP3;;49DATF·[¢s¥
QQFESTR ;2&;ie§-€:419§f9$9; ;-· 4 · `9·9
‘I’/ . 9 - 9 99R R`i` I9R; »``
`”AR *$¥* >TY ·» S? PIR -·1~ Ij;9 I‘99 ;
-
II-4 41I94¤

9R4‘ CREAT
9I9-
’-
. ”
AC
’1‘R


--4 9 _I99 -94 ..
I 49 L*BILIRUPé .9g9
-4; 9I-` P9`-
GP? A 9-i9 ?
IP1, A-9. ;9’ Q 11.`i :*IR9 ‘9-- #é`;;.;!¥:;iYL14-69 -¥9-
Ti; F PROTEFJIN/’ Si? afi - 'I I 94 7/i= ’-`4 9 E- 99;I4 A
9;I’ ~9’9 4`-‘ /499·4 { v —-`S A F} Q--E·@49-11/95%; PPTP 999‘
· ->- i I99» 19°‘»99 ‘
AII- €¥‘€A/.G71MTI<>§? R‘R9 -9 “ IS 49‘-R4 A99A9 ; 9I-I PQ 0—RIR·R 94-/I* i-S 9-”>; 9 I-- -I· I
-@9-`A§Y9SIERU1~4“IR0N§:>€.9{; -;9II- A I--9 -1,j-ii-$29499 `4`9
r;§@;344i€4_;4T-I‘Bc9 I I;I»· gee I-,` ·994 9*4-;Y‘i· 9?i?318I-[9
99`9 I-909 ·-444 20 »I‘` P4I I
`TCHOLESTEROL4 4‘-‘ YF ,9I—1 ?-if 999I ¥Q14?1·4`-· RI49- 49’-- ,;¥95§;Y 9”I9`
*i€'-PTRIGLYCERIIDE ' 9- _‘;9 2 I- S, I 4 -4 i I99/ * 12.3* E9 - ·II‘
,999F -ERRI1‘1N#/I VR`- 1* S9 i {*7 P.I9 ? -‘``- " -9 9-‘j 9-»
1I-·04 EFERRSITINI9 V~_/4{ 9 ·-S°I 1R4--RRVI }299¤P ‘> ~ `IAZA JT"-- iff /·—9/
TD -.9`” · _ > R904” 3 ’
»I·` ·9—9 ‘-‘· -I--- `‘9-
‘-=1 g -—}/ ? 9I’` ijiié-9/Ii¤;I*9A 9Ii--R9;-@9829Z 9.09 I ,-1RI`
‘`·‘ -4II9I I /`·S -IS99“R 9--9 S}*-*
·9999 1P__ 944 9--94;9 I 94`.4 I9‘4 IPI,4 II-9
"R`"‘f —°--/·- P-·- R‘/°I· i 9P` --99 I49R
-I-- -9 I-S-- `9` ’°—9S ¥ I--/I1-9 Q 9,9/ 999- 99¥ IPI -I4 -`9-
;cONTI NUEi REP-ORT » A -99- 9,9
I-9- 999-P-‘ I 4’°4 z EL R/ Qi? 9;V;9 ‘‘- -Z§;4e¥i‘iT*i>¥£ 9· R.-=9 QT? “ »--AI - ’;4` ;·’ FQ-}- V? 90S **R`
I? ’S’“ T -’-1I -9’· Case--24:03%-6véO-197294BCB 4‘D¤GPU-Ff¤S.¤i 9’‘.8 3%/43iI 4`49 ¥‘ -*#4/· E11Qd1§J 0<--=—0 9 II-9I 9`9I9`-I 9-·- J? ·`.9-9 9 I’-`9 I1/-9· ;¥‘ -‘;- ’4·/ -- ‘I9‘· _I;” 4I-4/PI · ,I- 99`· --I4

EXHIBIT 11
Case 2:03-cv-01729-RCB Document 83-13 FiIed10/31/2005 Page30f4

Laboratory Corporation of America
V SPECIMEN TYPE PRIMARY LAB REPORT STATUS -
232-237-6I36—0 S PD [ COMPLETE Page #: 1 ,
~ ADDITIONAL INFORMATION
` Z CLINICAL INFORMATION —Ti
FRSR FA$TING¤ N Y E cn- 84025063491 ` .
DOB: 2/25/1963 I
———— ·— ( PHYSICIAN ID. ( PATIENT ID. T
PATIENT NAME SEX ( AGE(YR./MOS.) MACABUHAYR . IOZOOI
MARTINEZ,FELIPE ( M ( 39 / 5 * —————€
—— b %ACCOUNT: ASPC - LEWIS _
---..-_...i2. _ ` 26700 S. HWY 85
DATE 0Fs1>Ec1MEN TIME DATE RECEIVED g DATE REPORTED TIME 1 E BUCKEYE AZ 853200000
8/20/2002 o;o0 8/21/2002 ( 8/26/2002 19:06 A 4009 Accouwr NUMBER: 02256542 , .
__A TEST RESULT LIMITS LAB
CMP12+8AC
. CHEMISTRIES I PD A
Glucose, Serum mg/dL 65 — 109 PD
Uxic Acid, Serum .1 mg/dL 2.4 — 8.2 PD
BUN 9 mq/dL 5 — 26 PD
Cxeatinine, Serum 1.1 mg/dL .5 — 1.5 PD
BUN/Creatinine Ratio 8 PA
Sodium, Serum 140 mmol/L 135 — 148 PD
Potassium, Serum 4.0 mmol/L 3.5 — 5.5 PD
Chloride, Serum 102 mmol/L 96 — 109 PD
Calcium, Serum 10.0 mg/dL 8.5 — 10.6 PD
Phosphorus, Serum 3.4 mg/dL 2.5 — 4.5 PD
Protein, Total, Serum 8.0 g/dL 6.0 — 8.5 PD
Albumin, Serum 4.4 q/dL 3.5 — 5.5 PD
Globulin, Total 3.6 q/dL I 1.5 — 4.5
A/G Ratio 1.2 1.1 — 2.5
> LT Bilirubin, Total 1.6H mg/dL .1 — 1.2 PD _?
Alkaline Phosphatase, Serum 75 IU/L 25 - 150 PD
LDH 143 IU/L 100 - 250 PD
> [ AST (SGOT) 52 H IU/L 0 - 40 PD _Q
> ALT (SGPT) 109 H IU/L 0 — 40 PD §
> GGT 68 H IU/L 0 — 65 PD
Iron, Serum 150 ug/dL 40 - 155 PD
. PD
LI P I DS PD
Cholesterol, Total 146 mg/dL 100 — 199 PD
> E; Triglycexides 229 H mg/dL 0 - 149 PD Ti
CBC WITH DI FFERENTIAL/PLATELET
White Blood Cell (WBC) Count 7.0 X 10-3/uL 4.0 - 10.5 PD
Red Blood Cell (RBC) Count 4.87 X 10-6/uL 4.10 — 5.60 PD
Hemoglobin 16.3 9/dL 12.5 - 17.0 PD
Hematocrit 46.3 % 36.0 - 50.0 PD
MCV 95 f L 8 0 — 98 PD
MCH 33.4 pg 27.0 — 34.0 PD
MCHC 35.2 g/dL 32.0 — 36.0 PD
RDW 13.2 % 11.7 — 15.0 PD
Platelets 183 X 10-3/uL 140 — 415 PD
Polys 56 % 40 — 74 PD
Lymphs 31 % 14 — 46 PD
Monocytes 10 2 % 4 - 13 PD
Results are Flagged in Accordance with Age Dependent Reference Ranges _/O
Continued on Next Page mmm] Sl MH-JABUHA0; ma 5 /2g 2/
Case 2:03-cv-01729-RCB Document 83-13 Filed 10/3W2®0'5085GBagie 4 of 4 at \O/I

Case 2:03-cv-01729-RCB

Document 83-13

Filed 10/31/2005

Page 1 of 4

Case 2:03-cv-01729-RCB

Document 83-13

Filed 10/31/2005

Page 2 of 4

Case 2:03-cv-01729-RCB

Document 83-13

Filed 10/31/2005

Page 3 of 4

Case 2:03-cv-01729-RCB

Document 83-13

Filed 10/31/2005

Page 4 of 4